Guardant Health, Inc.【GH】 研究開発費の推移

機能の使い方
(単位:千ドル) 研究開発費 前年比(%)
4Q25 98,264 +5.0%
3Q25 89,957 +3.0%
2Q25 87,449 +5.2%
1Q25 88,521 +5.6%
4Q24 93,543 +4.1%
3Q24 87,306 -7.0%
2Q24 83,102 -8.0%
1Q24 83,802 -10.0%
4Q23 89,856 -15.7%
3Q23 93,851 -6.2%
2Q23 90,359 +5.7%
1Q23 93,128 +13.9%
4Q22 106,578 +46.0%
3Q22 100,017 +40.9%
2Q22 85,455 +34.1%
1Q22 81,757 +47.3%
4Q21 73,021 +81.3%
3Q21 70,968 +95.8%
2Q21 63,724 +75.5%
1Q21 55,508 +50.0%
4Q20 40,282 +55.7%
3Q20 36,245 +47.5%
2Q20 36,319 +85.9%
1Q20 37,016 +126.9%
4Q19 25,875 +55.4%
3Q19 24,569 +72.4%
2Q19 19,532 -
1Q19 16,316 -
4Q18 16,652 -
3Q18 14,253 -